Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHRONVAC-C with Electroporation in Chronic HCV
NCT00563173Phase 2Unknown
- Sponsor
- Tripep AB
- Start
- Oct 2007
- Primary completion
- Apr 2010
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of chronvac-c in hepatitis C (HCV), sponsored by Tripep AB. Status: unknown.
02
Drugs
chronvac-c
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00563173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00563173.